Clinical Trials Logo

End Stage Renal Disease clinical trials

View clinical trials related to End Stage Renal Disease.

Filter by:

NCT ID: NCT02490904 Active, not recruiting - Clinical trials for End-stage Renal Disease

Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)

EPURE
Start date: October 19, 2016
Phase: Phase 3
Study type: Interventional

Assess the impact of eplerenone (initiated within 2 hours prior to patient departure to the operating room and administered for 4 days during the post-operative period) on graft function evaluated by the measurement of glomerular filtration rate at 3 months - variable strongly associated with long-term graft survival.

NCT ID: NCT02488200 Recruiting - Clinical trials for End Stage Renal Disease

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

Peridialysis
Start date: January 2015
Phase: N/A
Study type: Observational [Patient Registry]

The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered. 1. What factors influence unplanned DI? 2. What factors influence choice of dialysis modality? 3. What factors influence choice of dialysis access? 4. Why do physicians start dialysis? 5. What factors in the predialytic period and its immediate aftermath (the "peridialytic" period) influence prognosis?

NCT ID: NCT02487004 Not yet recruiting - Clinical trials for End-stage Renal Disease

The Study of Association Between Intradialysis Sodium Balance and Clinical Outcomes in Chronic Hemodialysis Patients

Start date: July 2015
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether the change of serum and dialysate sodium level during hemodialysis can influence on blood pressure and intradialytic weight gain in chronic hemodialysis patients.

NCT ID: NCT02486744 Terminated - Clinical trials for End Stage Renal Disease

Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

Start date: March 2015
Phase: Phase 1
Study type: Interventional

This will be a prospective observational study of Acthar Gel in Non-Diabetic Hemodialysis [NDHD] patients receiving dialysis for ≤ 2 years. The project will aimed at providing proof-of-concept data that 80 U two times [2x] week Acthar for 6 months is a safe and effective therapy for NDHD. Effectiveness of lower dose 40 U 2X week will also be determined. Therefore the study will be a repeated measures design (Time x condition) comparison of improvement in renal function, nutritional status, quality of life and physical performance resulting from Acthar therapy.

NCT ID: NCT02479451 Completed - Clinical trials for End Stage Renal Disease

Helping Olfaction and Nutrition On Renal Replacement

HONORR
Start date: October 2015
Phase: Phase 2
Study type: Interventional

This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.

NCT ID: NCT02479295 Completed - Renal Failure Clinical Trials

Straight Versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients

Start date: June 1, 2015
Phase: N/A
Study type: Interventional

This study compares the result of straight versus coiled Tenckhoff catheters for peritoneal dialysis patients. Recent meta-analysis of the peritoneal dialysis catheter type was in favor of straight catheters. The effects of straight versus coiled peritoneal dialysis catheters, however, are unclear. The investigators design an adequately powered randomized controlled study to evaluate the two types of double-cuffed peritoneal dialysis catheters. The primary objective is to assess whether straight peritoneal dialysis catheters can reduce the risk of catheter dysfunction that requires intervention. The investigators estimate that they would need to enroll 132 incident peritoneal dialysis patients in each group for the study to have 80% power to detect a difference between 7% and 15% in the primary endpoint of catheter dysfunction requiring intervention.

NCT ID: NCT02474719 Terminated - Clinical trials for End-stage Renal Disease

Transfer and Ultrafiltration In Peritoneal Dialysis

TULIPE
Start date: January 2015
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate the efficiency of an adapted and "alternate" peritoneal dialysis scheme in terms of sodium extraction and purification compared to an adapted conventional peritoneal dialysis scheme.

NCT ID: NCT02469467 Recruiting - Clinical trials for End Stage Renal Disease

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

Start date: June 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose is to evaluate the tolerability, safety and efficacy of VS-505 when given with meal for 8 weeks to hemodialysis patients with hyperphosphatemia

NCT ID: NCT02467530 Completed - Clinical trials for End Stage Renal Disease (ESRD)

Food Preparation Effects on Gut Bacteria in Patients on Peritoneal Dialysis

Start date: January 2015
Phase: N/A
Study type: Interventional

This is an intervention study of the effects of food preparation on the gut bacteria in patients with end stage renal disease on peritoneal dialysis. This is a dietary intervention consistent of consuming low amounts of advanced glycation end products (AGEs), the products of protein and sugar interaction during food processing and preparation using high direct heat.

NCT ID: NCT02460263 Completed - Clinical trials for End Stage Renal Disease

The EvAluation of TaBlo In-CLinic and In-HOme

TABLO
Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the Tablo Hemodialysis System when used In-Center by trained individuals and In-Home by trained Subjects.